发明名称 THE PERORALLY APPLICABLE DRUG FORM FOR THE TREATMENT OF CENTRAL CONDITIONS OF DOPAMINE DEFICIENCY
摘要 <p>The peroral form of the medicament contains a mixture consisting of 100 up to 250 parts of weight closed to levodopa 10 up to 25 parts of weight of carbidopa and 100 up to 200 weight percent related to the quantity of medications a.) mixture of polymers consisting of polyvinylalcohols with a different saponification degree or b) polyvinylalcohol saponified completely containing acetyl rest up to 3 percent or c) polyvinylacohol saponified partially with the acetyl rest content higher than 3 percent. This medication is suitable to be applied for healing of disease increasing as a result of dopamine shortage, for healing of Parkinson disease especially.</p>
申请公布号 SK278736(B6) 申请公布日期 1998.02.04
申请号 SK19920003692 申请日期 1992.01.23
申请人 WENZEL UDO;WEBER GUNTHER;METZNER JURGEN;DARR ALFRED;FREITAG SABINE;FLOTHER FRANK-ULRICH;ALBERT FRANK-MICHAEL;HAASE MARGIT;LEISTNER EDITH 发明人 WENZEL UDO;WEBER GUNTHER;METZNER JURGEN;DARR ALFRED;FREITAG SABINE;FLOTHER FRANK-ULRICH;ALBERT FRANK-MICHAEL;HAASE MARGIT;LEISTNER EDITH
分类号 A61K9/16;A61K9/20;A61K9/22;A61K31/195;A61K31/198;A61K47/30;A61P25/00;A61P25/16;A61P43/00;(IPC1-7):A61K31/195 主分类号 A61K9/16
代理机构 代理人
主权项
地址